United States · Federal contract register · Never sold to government

Managed healthcare

Updated 30 September 2026figures counted 30 September 2026all lines

Managed healthcare. Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Assay record ASY-US-1JMTPWU0H3 · Cite as: Assay Systems, “Managed healthcare: United States public buying for suppliers with no government contract”, https://assay-systems.com/register/us/never/managed-healthcare/

$63.4B
since January 2024
6,223 contracts
15
agencies
buying in the line
438
suppliers
share the line
$1.3B
ending in 12 months
665 contracts

If your company has never held a contract in the USAspending register, this is what the register records for the line managed healthcare as a whole since January 2024. No company is named here; the suppliers who hold the line are listed on its own page.

The line

since January 2024

Since January 2024 the line carries 6,223 contracts with $63,369,043,376 obligated from 15 agencies.

$22.5B
$20.2B
$20.6B
202420252026first 9 months

438 suppliers share it.

How the line is bought

since January 2024

817 contracts since 2024, with $243,966,223 obligated, went to the only supplier that applied.

1,808 more, with $872,229,951 obligated, were awarded directly, with no competition at all.

Ending within 12 months

by September 2027

665 contracts in the line, with $1,345,131,260 obligated, reach their end dates by September 2027.

357 of them, with $447,557,715 obligated, end in the same month, September 2026.

The extract for this line

Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.